According to the latest market research study published by P&S Intelligence, the auto injectors market made a total revenue of USD 1,011 million in 2023, and it will propel at a rate of 14.8% in the years to come, to touch a value of USD 2640.2 million in 2030.
The key factors powering the industry expansion include the mounting requirement for the drug administration ease, growing incidence of chronic and lifestyle associated diseases, and evolving healthcare technologies.
According to the WHO, over 16 billion injections are given on a yearly basis at a global level. So, the rising need for ease and safety throughout the procedure is powering the advance of the industry.
North America is the leader of auto injectors market, and this prominent position will persist in the years to come as well. This is for the reason that the continent provides ready reimbursement for the use of autoinjectors. Furthermore, the growing occurrence of anaphylactic shock will encourage the acceptance of auto-injectors filled with epinephrine. Moreover, the two nations in the region exhibit a high awareness with regards to self-administration drug delivery devices.
The fastest growth is observed by the APAC region, chiefly as a result of the growing occurrence of diabetes. Since diabetics need normal insulin administration, auto-injectors save the trouble of seeing a medic every time and, therefore, make them independent.
Moreover, the mounting occurrence of severe reactions as a result of food allergies is driving the requirement for epinephrine injections.
Due to the increasing occurrence of lifestyle and chronic diseases all over the world, the demand for auto injectors is on the rise. This trend wil continue in the near future as well.
